December 19, 2017 / 9:17 PM / 9 months ago

BRIEF-FDA Approves Pfizer's Bosulif To Treat A Type of Leukemia

Dec 19 (Reuters) - Pfizer Inc:

* U.S. FDA APPROVES PFIZER’S BOSULIF® (BOSUTINIB) FOR THE TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA (CML) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below